-
Table of Contents
Blood Pressure Effects of Phentermine Hydrochloride
Phentermine hydrochloride, commonly known as phentermine, is a prescription medication used for weight loss. It is classified as a sympathomimetic amine and works by suppressing appetite and increasing metabolism. While it has been proven to be effective in aiding weight loss, there have been concerns about its potential effects on blood pressure. In this article, we will explore the pharmacokinetics and pharmacodynamics of phentermine and its impact on blood pressure.
Pharmacokinetics of Phentermine
Phentermine is rapidly absorbed after oral administration, with peak plasma concentrations reached within 3-4 hours. It is primarily metabolized by the liver and excreted in the urine. The half-life of phentermine is approximately 20 hours, with a duration of action of 8-12 hours.
Phentermine is primarily metabolized by the enzyme CYP3A4, with minor contributions from CYP2D6 and CYP2C9. This means that drugs that inhibit or induce these enzymes may affect the metabolism of phentermine. For example, the antibiotic erythromycin, a CYP3A4 inhibitor, has been shown to increase the plasma concentration of phentermine by 30% (Henderson et al. 1999). On the other hand, the anticonvulsant phenytoin, a CYP3A4 inducer, has been shown to decrease the plasma concentration of phentermine by 20% (Henderson et al. 1999).
Phentermine is also known to have a high affinity for the serotonin transporter (SERT) and the norepinephrine transporter (NET). This means that it can increase the levels of these neurotransmitters in the brain, leading to appetite suppression and increased metabolism.
Pharmacodynamics of Phentermine
The primary mechanism of action of phentermine is through its effects on the hypothalamus, a region of the brain responsible for regulating appetite and metabolism. Phentermine stimulates the release of norepinephrine and dopamine, which activate the sympathetic nervous system and suppress appetite. It also inhibits the release of neuropeptide Y, a hormone that stimulates appetite (Bray et al. 2002).
Phentermine also has peripheral effects on the cardiovascular system. It increases heart rate and blood pressure by stimulating the release of norepinephrine and epinephrine from the adrenal glands. This is similar to the effects of exercise, which also increases heart rate and blood pressure through sympathetic nervous system activation.
Blood Pressure Effects of Phentermine
Given its effects on the sympathetic nervous system, it is not surprising that phentermine has been associated with increases in blood pressure. In a study of 108 obese patients, phentermine was found to increase systolic blood pressure by an average of 7.5 mmHg and diastolic blood pressure by 4.3 mmHg (Hendricks et al. 2011). However, it is important to note that these increases were within the normal range and were not considered clinically significant.
In another study of 76 obese patients, phentermine was found to increase systolic blood pressure by an average of 5.5 mmHg and diastolic blood pressure by 3.5 mmHg (Hendricks et al. 2011). These increases were also within the normal range and were not considered clinically significant.
It is worth noting that the blood pressure effects of phentermine may be more pronounced in individuals with pre-existing hypertension. In a study of 12 obese patients with hypertension, phentermine was found to increase systolic blood pressure by an average of 12 mmHg and diastolic blood pressure by 7 mmHg (Hendricks et al. 2011). Therefore, it is important for individuals with hypertension to closely monitor their blood pressure while taking phentermine.
Real-World Examples
Phentermine is commonly used in combination with other weight loss medications, such as topiramate, to achieve greater weight loss results. In a study of 248 obese patients, the combination of phentermine and topiramate was found to significantly reduce body weight and improve cardiovascular risk factors, including blood pressure (Garvey et al. 2012). This suggests that the blood pressure effects of phentermine may be mitigated when used in combination with other weight loss medications.
Another real-world example is the use of phentermine in athletes. While phentermine is not approved for use in athletes, it has been reported that some athletes use it for its weight loss and performance-enhancing effects. In a study of 10 male athletes, phentermine was found to significantly increase heart rate and blood pressure, as well as improve performance in a cycling test (Koch et al. 2013). However, it is important to note that this study was conducted in a controlled laboratory setting and the long-term effects of phentermine use in athletes are not well understood.
Expert Opinion
Overall, the blood pressure effects of phentermine are generally mild and within the normal range. However, individuals with pre-existing hypertension should closely monitor their blood pressure while taking phentermine. It is also important to note that phentermine should not be used in combination with other sympathomimetic medications, as this may increase the risk of adverse cardiovascular effects.
In conclusion, phentermine hydrochloride is an effective weight loss medication that works by suppressing appetite and increasing metabolism. While it may cause mild increases in blood pressure, these effects are generally within the normal range and can be mitigated when used in combination with other weight loss medications. As with any medication, it is important to consult with a healthcare professional before starting phentermine and to closely monitor blood pressure while taking it.
References
Bray, G. A., Ryan, D. H., & Gordon, D. (2002). Drugs in the treatment of obesity. Drugs, 62(7), 921-940.
Garvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., … & Day, W. W. (2012). Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. The American journal of clinical nutrition, 95(2), 297-308.
Henderson, G. L., Harkey, M. R., & Jones, P. G. (1999). Effects of erythromycin on the pharmacokinetics of phentermine in normal and obese subjects. Journal of clinical pharmacology,
